What is LOPJLB’s current signal on ABP?

LOPJLB’s latest quantitative signal on Abpro Corporation (ABP) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ABP in?

Abpro Corporation (ABP) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Abpro Corporation (ABP) do?

Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-…

Abpro Corporation (ABP)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.12+0.00%Close

SELLCRISIS · day 61

RANGE

DATA 2026-03-16

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Market cap: $243,149
Beta: -0.00

P/E (TTM): -0.24

1W: +20.00%
1M: -85.54%

vs SPY 1W: +18.84%
vs SPY 1M: -88.53%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

FAQ

What is LOPJLB’s current signal on ABP?: LOPJLB’s latest quantitative signal on Abpro Corporation (ABP) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is ABP in?: Abpro Corporation (ABP) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does Abpro Corporation (ABP) do?: Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-…

Key stats

Prediction markets

Company news

FAQ